MRK vs LLY
Merck & Co. vs Eli Lilly and Company — AI-powered side-by-side comparison
| Metric | MRK | LLY |
|---|---|---|
| AI Score | 56 | 61 |
| Price | $125.97 | $1,216.24 |
| P/E Ratio | 35.46× | 45.75× |
| ROE | 17.9% | 101.3% |
| Revenue Growth YoY | 2.9% | 47.4% |
| Gross Margin | 78.1% | 82.8% |
| Debt / Equity | 0.94× | 1.60× |
| Dividend Yield | 2.6% | 0.6% |
| RSI (14) | 54.6 | 69.6 |
| Beta | 0.2095 | 0.5016 |
| Expected Upside | — | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
MRK Full Analysis
LLY Full Analysis